About Adtalem Global Education Inc. Common Stock (ATGE)
Adtalem Global Education Inc is a leading provider of educational services and professional training, focused on equipping individuals with the skills and knowledge necessary for successful careers in various fields. The company operates a diverse portfolio of institutions and brands, offering programs in healthcare, business, technology, and other disciplines, catering to a wide range of learners from traditional college students to working professionals seeking further development. With a commitment to enhancing educational access and workforce readiness, Adtalem strives to empower students through innovative learning solutions, partnerships, and a strong emphasis on aligning curricula with industry demands. Read More
Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis.
The DJS Law Group announces that it is investigating claims on behalf of investors of Adtalem Global Education Inc. (“Adtalem” or “the Company”) (NYSE: ATGE) for violations of the securities laws.
Shares of vocational education company Adtalem Global Education (NYSE:ATGE)
fell 28.3% in the afternoon session after the company reported third-quarter 2025 results that beat Wall Street estimates, but a weak forward-looking revenue forecast appeared to spook investors.
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.
Vocational education company Adtalem Global Education (NYSE:ATGE) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.8% year on year to $462.3 million. The company expects the full year’s revenue to be around $1.92 billion, close to analysts’ estimates. Its non-GAAP profit of $1.75 per share was 10.9% above analysts’ consensus estimates.
Vocational education company Adtalem Global Education (NYSE:ATGE) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 10.8% year on year to $462.3 million. The company expects the full year’s revenue to be around $1.92 billion, close to analysts’ estimates. Its non-GAAP profit of $1.75 per share was 10.9% above analysts’ consensus estimates.
Adtalem Global Education Inc. (NYSE: ATGE), the largest healthcare educator in the United States, today reported first quarter fiscal year 2026 results (ended Sept. 30, 2025). The Company continues to transform higher education by training the next generation of professionals at an industry-leading scale.
Vocational education company Adtalem Global Education (NYSE:ATGE)
will be reporting results this Thursday after market close. Here’s what investors should know.
Even if a company is profitable, it doesn’t always mean it’s a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Adtalem Global Education, the nation’s largest health care educator, is expanding access to medical education by creating clear, scalable pathways into medical school. To meet the growing demand for physicians worldwide, Adtalem’s medical institutions, Ross University School of Medicine (RUSM) and American University of the Caribbean School of Medicine (AUC), are launching programs that help qualified students move seamlessly from preparation to practice.
Adtalem Global Education (NYSE: ATGE) and Google Cloud (NASDAQ: GOOGL) have announced a groundbreaking partnership to launch a comprehensive Artificial Intelligence (AI) credential program tailored specifically for healthcare professionals. This pivotal initiative, unveiled on October 15, 2025, directly confronts a critical 'AI readiness gap' prevalent across the healthcare sector, aiming to equip both aspiring and [...]
Adtalem Global Education Inc. (NYSE: ATGE), the nation's largest healthcare educator, today announced the launch of the first comprehensive AI credentials program that will be designed specifically for healthcare professionals at scale, reaching students and practicing clinicians across its institutions and partner health systems. Through a strategic partnership with Google Cloud, Adtalem will deliver curriculum powered by Google Cloud's industry-leading AI technology, providing students with direct, hands-on experience with tools reshaping clinical practice.
Adtalem currently trades at $140 and has been a dream stock for shareholders. It’s returned 429% since October 2020, blowing past the S&P 500’s 86.5% gain. The company has also beaten the index over the past six months as its stock price is up 33.8% thanks to its solid quarterly results.
New York, NY – October 9, 2025 – Phoenix Education Partners Inc. (NYSE: PXED), the parent company of the University of Phoenix, successfully re-entered the public market today with a strong debut on the New York Stock Exchange. The online education provider's initial public offering (IPO) was priced at $32.00 per
In a highly anticipated move that has sent ripples through the education and financial sectors, the University of Phoenix (NYSE: PXED) has made its official return to the public markets, with its shares commencing trading on the New York Stock Exchange (NYSE) today, October 9, 2025. Priced at $32.00
The stocks in this article are all trading near their 52-week highs.
This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.
New York, NY – October 2, 2025 – Phoenix Education Partners, Inc., the parent company of the venerable University of Phoenix, is poised to make its highly anticipated return to the public stock market with an Initial Public Offering (IPO) slated for October 8, 2025. Trading under the ticker symbol (NYSE: PXED)
Adtalem Global Education Inc. (NYSE: ATGE), the largest healthcare educator in the United States, announced today it will release its first quarter fiscal year 2026 results on Thursday, Oct. 30, 2025, after financial markets close, followed by a conference call at 4:00 p.m. CT (5:00 p.m. ET) the same day to discuss the results.
